Intravenous Ibuprofen for Laparoscopic Bariatric Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Obesity
Interventions
DRUG

Intravenous Ibuprofen

800 mg Ibuprofen IV every 6 hours starting preoperatively (5 doses).

DRUG

Saline

Placebo control

Trial Locations (1)

10461

Jacobi Medical Center, The Bronx

Sponsors
All Listed Sponsors
collaborator

Cumberland Pharmaceuticals

INDUSTRY

collaborator

Sagatech Electronics Inc, Alberta, Canada

UNKNOWN

lead

Jacobi Medical Center

OTHER

NCT01707251 - Intravenous Ibuprofen for Laparoscopic Bariatric Surgery | Biotech Hunter | Biotech Hunter